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PREFACE 
Aims of the Study 
Until recently minimal insight involving the role of macrophages in peritoneal wound 
healing has been achieved.  The objective of this study is to determine the role that 
macrophages play in the development of post-operative adhesions.  The central hypothesis is 
that surgical-induced hypoxia triggers a pro-inflammatory signal, leading to the activation and 
recruitment of resident and infiltrating macrophages to traumatized tissue.  This hypothesis has 
been formulated on the basis of strong preliminary and published data, which suggest that 
hypoxia plays a major role in the development of the adhesion phenotype, an integral part to 
post-operative adhesion development (1, 11-16, 28-34).  This phenotype is characterized by a 
reduction in plasminogen activator activity, increased extracellular matrix deposition, increased 
cytokine production, and reduced apoptosis (1, 11-16).  Furthermore, we have shown that 
exposure of normal peritoneal fibroblasts to hypoxia, irreversibly induces the adhesion 
phenotype (1, 28-34).  The rationale for this study is that hypoxia, through the induction of HIF-
1and TGF-1 expression, induces the expression of TGF-1, type I collagen and VEGF, not 
only in fibroblasts but also in macrophages.  
We examined the hypothesis by pursuing three specific aims: 
1. Determine whether macrophages express adhesion phenotype markers TGF-1, 
type I collagen and VEGF, and whether this expression is induced by hypoxia.  
2. Determine whether the adhesion phenotype is induced in macrophages through a 
HIF-1 dependent mechanism following hypoxia exposure.   
3. Determine whether human macrophages stimulate normal peritoneal fibroblasts to 
acquire the adhesion phenotype following hypoxia exposure. 
 
   xiii
Collectively, the outcome from this study will support the role of macrophages in the 
development of the adhesion phenotype and thus may involve an important role of innate 
immunity in the pathogenesis of post-operative adhesion development. 
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CHAPTER 1 
Introduction 
Post-operative Adhesions 
Post-operative adhesion development remains a very frequent occurrence that is often 
unrecognized by physicians due to the limited ability to conduct early second-look surgeries.  
We and others have had the opportunity to perform such studies and found that nearly 85% of 
patients examined developed adhesions (1, 2).  Adhesions are abnormal fibrous connections that 
develop between tissues and organs as a result of inflammation, but most frequently as a sequel 
to surgical trauma.  Consequently, adhesions are the major contributors to small bowel 
obstruction, infertility, and severe pelvic and abdominal pain (1-3).  Managing adhesions and 
their related complications affects the health-care system drastically.  The prolongation of 
hospital stay, readmissions, surgical intervention, and potential litigation impose an enormous 
economic burden (4).  Within the United States alone, adhesion-related issues, cost the 
healthcare system over $2.24 billion annually (1, 2).  Therefore, adhesions are considered the 
most frequent and costly problem associated with surgery (3).   
In spite of the current use of less traumatic surgical methods, including microsurgical and 
laproscopic techniques, a high incidence of adhesion development persists.  Laparoscopic lysis 
of adhesions is optional for patients experiencing chronic adhesion-related pelvic pain, though 
adhesions have been shown to reform at one or more sites in almost all patients who undergo 
adhesiolysis, and at over two-thirds of the actual sites where adhesiolysis was performed (5-7).  
Having awareness of the many reasons to address the problem of adhesions, and the large 
number of surgical procedures performed each day in the United States, our understanding of 
peritoneal healing is extremely limited.  However, one thing stands out: some patients heal 
adhesion-free, while others develop severe scarring from seemingly equivalent procedures.  The 
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basis for this difference is completely unknown.  Our understanding of these findings has 
focused our attention to better understanding molecular mechanisms responsible for adhesion 
development.  Improved understanding of these mechanisms may allow clinicians to inhibit or 
selectively limit the development of post-operative adhesions. 
Healing of the Peritoneum 
In order to better understand mechanisms involved in the pathophysiology of peritoneal 
wound healing and postoperative adhesion development, we must first examine the anatomy of 
the normal peritoneum.  The peritoneum is a serous membrane that lines the abdominal cavity 
and consists of mesothelial cells whose primary function is to ensure free movement of 
abdominal structures.  In doing so, mesothelial cells produce a lubricating fluid to minimize 
friction within the peritoneal cavity.  Trauma to the peritoneum resulting from infection, 
inflammatory disease, and/or surgical procedures, disrupts this activity and promotes adhesion 
development.  Subsequently, healing in the presence/absence of adhesions is determined by four 
sequential, yet overlapping phases; these include blood homeostasis, inflammation, cell 
proliferation, and tissue remodeling (1, 8).  Mesothelial cells, fibroblasts, inflammatory, and 
immune cells are integral to these processes (3).  Substances released from these cells regulate 
fibrinolytic activity, tissue remodeling, angiogenesis, and extracellular matrix turnover, 
processes that are central to the development of post-operative adhesions (1).   
While many phases of peritoneal wound healing resemble dermal wound healing, two 
fundamental differences exist.  First, in contrast to dermal injuries, which heal from the edges 
toward the middle (such that time of healing is dependent on the surface area of the lesion), 
peritoneal injuries are thought to heal by differentiation of underlying progenitor cells (such that 
healing occurs throughout the lesion simultaneously) (1, 9).  Second, peritoneal wounds are 
continuously exposed to factors present in the peritoneal fluid, such as growth factors and 
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cytokines (1, 10).  These substances are released from various cells that are resident to the 
wound; therefore, an autocrine/paracrine feedback is an important component of peritoneal 
healing.  For normal peritoneal healing to occur, optimal concentrations of these signaling 
molecules must be present.  Therefore, inhibition or over-stimulation may lead to impairment 
(nonhealing) or excessive scar tissue (adhesions). 
The Adhesion Phenotype 
To date, approaches to limit adhesion development have primarily focused on minimizing 
surgical trauma such as meticulous attention to operative techniques, delicate purposeful tissue 
handling, and uncompromising hemostasis.  Another approach utilizes internal barriers, such as 
Seprafilm (Genzyme, Cambridge, MA), Interceed (Gynecare, Somerville, NJ), and Adhesion 
reduction Solution (ADEPT; Baxter BioSurgery, Deerfield, IL), to separate surgically injured 
tissue from non-injured tissue surfaces during the initial postoperative timing period while 
remesothelialization is occurring, a process that is usually expected to take 3 to 5 days (4).  Over 
time these approaches have not been completely effective in reducing adhesion development 
therefore additional research focusing on mechanisms involved in peritoneal wound healing is 
critical.  Delineating mechanisms that are paramount to peritoneal healing may provide a more 
successful approach for adhesion prevention.  Our laboratory has a long-standing interest in 
studying molecular mechanisms involved in the pathogenesis of postoperative adhesions.  We 
have established primary cultures of fibroblasts isolated from normal peritoneum and adhesion 
tissues (from the same patients) and characterized differences between these two cell lines at the 
molecular level (1, 11).  Adhesion fibroblasts, when compared to normal peritoneal fibroblasts, 
exhibit a reduction in plasminogen activator activity (lower tPA and higher PAI-I), increased 
angiogenesis (increased VEGF), increased extracellular matrix deposition (higher type I collagen 
and fibronectin), increased cytokine production (higher TGF-1), and reduced apoptosis (higher 
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Bcl and lower Bax), collectively known as the “adhesion phenotype” (1, 11-16).  Additionally, 
we have established an animal model as well as an ex vivo model to further investigate molecular 
mechanisms in vivo. 
Hypoxia and Oxidative Stress 
Recently, we have gathered an immense amount of compelling evidence to support the 
hypothesis that surgical-induced hypoxia is the initiating factor leading to post-operative 
adhesion development.  In support of this hypothesis, we have shown that hypoxia irreversibly 
induces the adhesion phenotype in normal peritoneal fibroblasts (1, 17-23).  However, the 
mechanism by which hypoxia acts is not fully understood.  During the first five minutes of 
hypoxia, there is a significant production of free radicals, either through an increase in reactive 
oxygen species (ROS) or by decreasing ROS scavengers (24-28).  This increase in ROS has 
significant consequences, such as stimulation of cellular proliferation, promotion of mutations 
and genetic instability, and ultimately, alteration in both the phenotype and genotype (24, 29-30).   
We have shown that hypoxia-generated superoxide (O2●−), a potent reactive oxygen 
species (ROS), induces the development of the adhesion phenotype (31).  Under normoxic 
conditions, ROS are maintained at optimal levels by specific scavenging systems (31-33).  This 
process is achieved by various enzyme systems that neutralize toxic oxidants, such as ROS.  
Superoxide dismutase (SOD), an anti-oxidizing enzyme, catalyzes the conversion of superoxide 
(O2●−) to hydrogen peroxide (H2O2), which subsequently leads to the conversion of water by 
catalase or glutathione (GSH) peroxidase coupled with glutathione reductase.  We have shown 
that scavenging O2●−, by superoxide dismutase (SOD), restores adhesion markers in adhesion 
fibroblasts to levels observed in normal peritoneal fibroblasts (31).  Also, scavenging O2●− by 
SOD during hypoxia exposure inhibits the development of the adhesion phenotype in normal 
peritoneal fibroblasts.  Similarly, a role for ROS has been established in adhesion formation 
5 
 
which is derived from the observation that ROS scavengers reduce adhesion formation following 
open surgery in different animal models (30).  It has been shown that SOD reduces adhesion 
formation induced by vascular obstruction/reperfusion of an ileal segment in rats (30).  Based on 
these observations and others we have concluded that hypoxia, through the production of ROS, 
plays a significant role in the pathogenesis of postoperative adhesion development.  More 
specifically, acute oxidative stress in the peritoneum induces mesothelial cell loss or dysfunction, 
peritoneal fibrosis, and more importantly intra-abdominal adhesion formation (34).   
Homeostatic Response to Hypoxia:  HIF-1 
Hypoxia initiates transcription of a number of genes that help to sustain O2 supply to 
tissues and to enhance cell survival during severe O2 deprivation.  One of these classic cellular 
adaptations to ensure O2 availability is the manifestation of hypoxia-inducible factor-1alpha 
(HIF-1) (35).  Hypoxia-inducible factor (HIF) is a major transcriptional regulator of cell 
metabolism and stress caused by oxygen deficiency (hypoxia) (35).  The significance of HIF was 
recently demonstrated by a significant decrease in mRNA expression of vascular endothelial 
growth factor (VEGF) and glycolytic enzymes seen during hypoxia in HIF-1-deficient murine 
embryonic stem cells (36-38).  At the tissue level VEGF stimulates the formation of new 
capillaries and at the cellular level glycolytic enzymes and glucose transporter 1/3 (GLUT1 and 
GLUT3) gene products are enhanced (36-38).  
The HIF protein is composed of two subunits, an oxygen-sensitive HIF-1 subunit and a 
constitutively expressed HIF-1β subunit.  Therefore, HIF-1 expression, and thus the formation 
of the HIF-1-HIF-1 complex, is largely dependent on O2 availability (Diagram 1).  Activity of 
the HIF-1/HRE pathway, under optimal oxygen conditions, is substantially suppressed by the 
activity of prolyl hydroxylases (PHD) which modify HIF-1 at specific prolyl and asparingyl 
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amino acid residues (35-37, 39-41).  This 
results in polyubiquitination of HIF-1 by 
von Hippel-Lindau tumor suppressor protein 
(VHL) (35-37).  Ultimately, the HIF-1 
subunit undergoes proteasomal degradation 
and is unable to form the heteromeric, HIF 
complex.  Post-translational modifications 
(hydroxylation) are inhibited during hypoxia 
(35).  Unmodified HIF-1 is then able to 
migrate to the nucleus and bind HIF-1(35).  
The HIF-1/HIF-1 complex stabilizes and 
goes on to regulate HIF-dependent gene 
expression.  Upon complex formation HIF 
controls transcription by associating with 
hypoxia response elements (HREs) in the 
promoter region of a wide array of genes (35-
37).  HIF-controlled pathways influence 
metabolism, angiogenesis, cell differentiation, 
and apoptosis, and also have implications for 
normal physiology and development (35-37).   
ROS have been proposed to participate in the signal transduction process mediating the 
stabilization of HIF-1 during hypoxia (42).  Under hypoxic conditions, mitochondria participate 
in a ROS burst (42).  When the partial pressure of oxygen is reduced, electrons bind to molecular 
 
Diagram 1: Stability and Transcriptional 
Activity of HIF-α. In the presence of O2 and 
cofactors, Fe+2 and 2-OG, PHDs hydroxylate 
HIF-1α. Modified HIF-1α recognized by the 
E3 complex that is followed by E2/E1-
mediated ubiquitylation and degradation in the 
26S proteasome. FIH-1-mediated N-
hydroxylation prevents recruitment of 
p300/CBP transcriptional coactivators. In the 
absence of O2, PHDs and FIH-1 are 
inactivated. Inmodified HIF-1α translocates to 
the nucleus, dimerizes with HIF-β, recruits 
p300/CBP, and induces the expression of its 
target genes via binding to the HRE. BTM, 
basic transcriptional machinery; E1, ubiquitin-
activating enzyme; E2, ubiquitin-conjugating 
enzyme; E3, ubiquitin ligase; FIH-1, factor 
inhibiting HIF-1; HRE, hypoxia-response 
element; 2OG, 2-oxoglutarate; PHDs, prolyl 
hydroxylases; Ub, ubiquitin; VHL, von 
Hippel-Lindau protein. (93) 
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oxygen, forming superoxide (O2●−) (42).  Superoxide is then converted to H2O2 by SOD.  The 
resulting H2O2 efflux into the cytosol exerts an inhibitory effect on PHD activity, allowing 
HIF1α to accumulate, dimerize with HIF1β, and translocate into the nucleus where it modulates 
the expression of genes that favor survival under hypoxic conditions (42). 
The Role of Cytokines:  TGF-1 
In addition to HIF-1 transforming growth factor beta (TGF-) also plays a predominant 
role in peritoneal wound healing.  Under normal conditions TGF- regulates inflammation, 
angiogenesis, and extracellular matrix (ECM) turnover (43-47).  Excessive TGF- exposure 
exaggerates these processes thus promoting the development of adhesions (43).  We have shown 
that hypoxia significantly increases the expression of TGF- isoforms and their receptors in 
multiple cell types (28, 30, 48-50). Hypoxia-induced TGF-1 expression has been shown to 
control the stability of HIF-1α through the regulation of prolyl hydroxylase (52).  In addition, 
TGF-β1 can influence the accumulation of HIF-1α in normoxic conditions which further 
exacerbates TGF-1’s ability to promote adhesions even following reoxygenation (52).  
Transforming growth factor  (TGF-) exists in three isoforms (TGF-1, TGF-2 and 
TGF-3).  Practically all cells have receptors for the TGF-s, and at least one of the isoforms is 
produced in all tissues (53-57).  Unlike other cytokines, TGF- is secreted in a latent form. TGF-
 and the non-covalently bound latency-associated peptide (LAP; derived from the N-terminal of 
the TGF- precursor), must be released for activation.  Therefore, several possible modes of 
activation exist.  It is thought that proteolysis by plasmin and other proteases is an important 
mechanism (53-57).  LAP-TGF- is usually secreted as a large latent complex consisting of 
LAP-TGF- covalently bound to a latent TGF--binding protein (LTBP).  LTBPs serve as 
structural components of the ECM and modulators of TGF- availability.  
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TGF- reecptors have three components: type I (RI, or ALK5); type II (RII) and type III 
(RIII, or β-glycan).  RIII binds TGF- (all isoforms) and recruits TGF- to RII, which then 
phosphorylates RI to form a heterotetrameric serine/threonine kinase complex.  In turn, RI 
phosphorylates Smad2 and Smad3 (receptor-associated Smads (R-Smads)), and the latter form a 
heteromeric complex with Smad4, which translocates to the nucleus, binds to DNA and regulates 
transcription.  In contrast to Smads 2-4, Smad7 inhibits TGF- signaling. 
Diagram 2: Activation of R- and Co-Smads. Upon 
ligand-induced heteromeric complex formation and 
activation of type I and type II receptors, R-Smads 
are phosphorylated and form heteromeric complexes 
with Co-Smads that translocate into the nucleus, 
where they control the expression of target genes in a 
cell type specific manner. Nonactivated Smads can 
be retained in cytoplasm through association with 
microtubules (MT). The recruitment of Smad2 to the 
TGF- receptor complex has been shown to involve 
a FYVE domain containing protein termed Smad 
anchor for receptor activation (SARA). 
Transcriptional modulation by Smads is achieved 
through complex formation with, e.g. transcriptional 
coactivators like p300/CBP and interacting 
transcription factors. R- and Co-Smads appear to 
form preferentially trimers consisting of one Co-
Smad and two R-Smads. However, Smad complexes 
with other stoichiometry cannot be excluded (94). 
 
 
Diagram 3: Mechanism of Action of I-Smads 
Negative regulation of TGF-/Smad signaling can 
occur through I-Smads that prevent activation of R-
Smads or compete with Smad4 for heteromeric 
complex formation with activated R-Smads. I-
Smads are induced by TGF- family members and 
they may thus participate in a negative feedback 
loop (94). 
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The Role of Angiogenesis:  VEGF 
Stimulation of cells with TGF- can result in the activation or inhibition of several genes 
including VEGF, a major angiogenic growth factor (53-57).    Angiogenesis is involved in the 
restructuring process following tissue injury by regulating regeneration of capillaries, from pre-
existing vasculature, to compensate for the loss of nutrients and oxygen (1, 8-10, 58-60).  
Capillaries are needed in all tissues for exchange of nutrients and metabolites.  Changes in 
metabolic activity, as a result of tissue trauma, leads to proportional changes in angiogenesis and 
hence, proportional changes in capillarity (58-60).  Oxygen plays a pivotal role in this process.  
More specifically, hypoxia potentiates angiogenesis, in part, by increasing both HIF-1 and 
TGF-1 levels subsequently leading to the up-regulation of VEGF (1, 45, 61-66).  Additionally, 
VEGF stimulates endothelial cell proliferation and increases vascular permeability.   
Most control systems of the body, including 
angiogenesis, act by a negative feedback mechanism.  
When oxygenation is inadequate, the tissues become 
hypoxic, and this hypoxic signal induces or suppresses 
various proangiogenic or antiangiogenic substances (69). 
The increase in neovascularization promotes oxygen 
delivery to the tissue thereby increasing both capillary 
surface area and maximum blood flow to the tissues, and 
decreasing diffusion distances between capillaries (69).  
When oxygen levels normalize, proangiogenic and 
antiangiogenic factors return to normal levels and 
development of the vasculature is minimized, thereby closing the feedback loop (69).   
 
Diagram 4: Regulation of 
Angiogenesis during Hypoxia. 
HIF-1 and TGF-1 activates 
VEGF to stimulate angiogenesis 
during hypoxia. Over expression 
of VEGF favors adhesion 
formation.
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Excessive vascularization promotes adhesion development therefore, therapeutic 
applications targeting angiogenic pathways, specifically VEGF, have potential to reduce 
peritoneal adhesions (67, 68).  For example, Bevacizumab has been shown to decrease adhesion 
formation following laparotomy in rats by blocking VEGF receptor occupancy (68).  Binding of 
VEGF to its respective receptor results in receptor dimerization and ligand-dependent receptor 
tyrosine kinase phosphorylation, thereby activating intracellular signaling pathways involved in 
endothelial cell proliferation, migration, survival, sprouting, and tube formation, as well as up-
regulation of molecules involved in degradation of the extracellular matrix.   
The Role of the Extracellular Matrix: Type I Collagen 
The earliest event in tissue repair involves deposition of fibrin-rich exudates, also 
referred to as provisional matrix (1).  This process is critical to the initiation of peritoneal wound 
healing, though its resolution is also essential to healing without adhesions.  Fibrin functions to 
restore injured tissues, and under normal circumstances are only temporary (29, 70-72).  Lack of 
fibrin degradation allows the provisional matrix to become more organized which results in 
vascularization (increased VEGF) and collagen deposition.  The organization of these fibrin 
bands over time and their transformation into mature fibrous adhesions is what allows adhesions 
to persist.   The fibrinolytic pathway is responsible for degrading these filmy, fibrinous adhesions 
though following surgery this pathway is limited due to decreased blood supply (29, 70-72).  
Plasminogen activators convert plasminogen to plasmin, and are inhibited by plasminogen 
activator inhibitor (PAI).  Plasmin degrades fibrin and also activates collagenases which go on to 
degrade type I collagen.  We have shown that hypoxia, in addition to TGF-1, decreases the 
fibrinolytic pathway by increasing PAI expression while decreasing PA expression (29, 70-72).  
In addition to the PA/plasmin system the outcome of normal wound healing or 
impairment, such as adhesion development, largely depends on extracellular matrix turnover.  
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Type I collagen is the most abundant extracellular matrix protein.  Several studies have shown 
 
that over-expression of type I collagen leads to adhesion formation (28).  Hypoxia and hypoxia-
induced TGF-1 expression enhance type I collagen expression and therefore promote 
conditions favorable for adhesion development (30, 73-76).  Matrix metalloproteinases (MMPs) 
degrade various components of the ECM, including type I collagen, and are induced in tissues 
undergoing extensive remodeling, as seen during inflammation and wound healing.  The 
Adhesions formed
Persistent fibrinous 
mass
Release of cytokines, growth 
factors, others   
Fibrin deposition
Tissue Insult:  Hypoxia
Fibrous clot-like adhesions     
form (3-5 days)
No adhesions formed
Resolution of fibrinous
mass
 
Diagram 5: Normal vs. pathologic conditions of peritoneal wound healing. Surgery 
causes damage to the mesothelium and results in a hypoxic microenvironment. Hypoxia leads 
to accumulation of a proteinaceous exudate at the injured site. These factors regulate fibrin 
deposition and are responsible for driving the recruitment of multiple cell types, such as 
fibroblasts, mesothelial cells, and macrophages, to the injured site. The earliest event in tissue 
repair involves deposition of fibrin-rich exudates, also referred to as provisional matrix.  This 
process is critical to the initiation of peritoneal wound healing, but its resolution is also 
essential to healing without adhesions. Fibrin functions to restore injured tissues and under 
normal circumstances is only temporary. The fibrinolytic pathway is responsible for 
degrading these filmy, fibrinous adhesions though following surgery this pathway is limited 
due to decreased blood supply. Lack of fibrin degradation allows the provisional matrix to 
become more organized. The organization of these fibrin bands over time and their 
transformation into mature fibrous adhesions is what allows adhesions to persist.  
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proteolytic activity of MMPs is inhibited by tissue inhibitor of matrix metalloproteinases 
(TIMPs), which also influences cell growth, angiogenesis, and tumor invasion.  Therefore the 
balance between the expression of MMPs and TIMPs is critical to normal wound healing.  In 
general, hypoxia inhibits the expression of MMPs and increases TIMPs, thus decreasing matrix 
degradation and increasing fibrosis (73-76).  Furthermore, hypoxia-induced TGF-1 expression 
decreases MMPs which furthers minimizes the proteolytic ability of MMPs to maintain over-
expressed ECM factors, such as type I collagen, following tissue injury (30, 73-76). 
Factors involved in the fibrinolytic pathway and ECM turnover have been popular targets 
in reducing adhesion development (70, 74-75, 77).  For example, Interceed, an adhesion barrier, 
reduces the incidence, extent, and severity of adhesions by physically separating tissue layers 
during the healing process.  We have shown that Interceed increases the expression of PA and 
the PA/PAI ratio thereby promoting dissolution of fibrin which highlights Interceed’s role as a 
barrier as well as having biologic effects (70).  On the other hand, Tisseel, a fibrin sealant, 
facilitates initiation of coagulation at the wound site and thereby restores tissue stability by 
ensuring hemostasis.  We have shown that Tisseel enhances the expression of MMPs while 
reducing TIMP expression (74-75).  Collectively, these observations demonstrate the ability of 
internal tissue barriers to successfully reduce post-operative adhesion development thus 
implicating the importance of factors involved in tissue remodeling. 
A Proposed Role of Macrophages in Adhesion Development 
Until recently minimal insight involving the role of macrophages in peritoneal wound 
healing has been explored.  Macrophages are evolutionarily ancient cells deriving from the 
primordial amoeba that evolved in the hypoxic atmosphere and adapted to normoxic conditions.  
Consequently, macrophages are highly versatile cells that are able to function under adverse, 
environmental conditions, such as hypoxia.  Extensive monocyte extravasation is an early event 
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in the onset of inflammation and wound healing (78-81).  Chemo-attractants, released in the 
environment as a result of inflammation, establish chemo-tactic gradients that are responsible for 
driving the recruitment of macrophages within avasular and necrotic, hypoxic areas of diseased 
tissue (80-81).  Macrophages travel toward injured tissue as monocytes released from systemic 
circulation and subsequently undergo a process of differentiation and activation.  Hypoxia is 
known to induce marked changes in the secretory activity of macrophages thereby eliciting 
cellular processes including, angiogenesis, ECM turnover, inflammation, and phagocytosis (78-
79).  The objective of this study is to determine the role of macrophages in the development of 
post-operative adhesions.   
Materials and Methods 
Cell cultures 
Macrophages:  Macrophages, from a human macrophage cell line, EL-1 (American Type 
Culture Collection Global Bioresource Center Manassas, Virginia), was cultured in Iscove’s 
Modified Dulbecco Medium supplemented with 10% fetal bovine (FBS) and 2% penicillin and 
streptomycin.  The next day macrophages were centrifuged for 5 min at 1800 RPM.  Old media 
was discarded and macrophages were re-suspended in 10 mL of PBS buffer and re-centrifuged.  
Macrophages were transferred into a fresh 100 mm cell culture dish with pre-warmed media and 
placed in a 37°C incubator (95% air and 5% CO2).  Once confluence was reached dishes were 
sub-cultured (1:3 split ratio).  Studies were conducted using passages 3-5 to maintain 
comparability to ensure normal phenotype of cells was not compromised.  Based on previous 
experience with these cells, variability is observed following splitting of cells more than 5 times.   
Fibroblasts:  Collection and isolation of fibroblasts have been previously described (1).  
At the initiation of surgery adhesion tissue and normal parietal peritoneal tissue from the anterior 
abdominal wall lateral to the midline incision were excised from patients undergoing laparotomy 
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for pelvic pain, following entry into the abdominal cavity (1).  Normal peritoneum was at 
minimum three inches from any adhesions. Subjects did not have an active pelvic or abdominal 
infection and were not pregnant.  All patients gave informed written consent to tissue collection, 
which was conducted under a protocol approved by the Wayne State University Institutional 
Review Board.   
Harvested tissue samples from five women were immediately placed in standard media 
[Dulbecco’s modified Eagle’s medium (DMEM) containing 10% fetal bovine serum (FBS), 2% 
penicillin and streptomycin].  Tissues were cut into small pieces in a sterile culture dish and 
transferred into another fresh T-25 flask with 3 ml of dispase solution (2.4 U/ml; GIBCO BRL, 
Invitrogen Corporation, Life Technologies, Carlsbad, California).  The flasks were incubated 
overnight at 37°C in an environ-shaker (LAB-LINE Instruments, Barnstead International, 
Dubuque, Iowa).  The samples were then centrifuged for 5 min at 1400 g, transferred into a fresh 
T-25 flask with pre-warmed DMEM and placed in a 37°C incubator (95% air and 5% CO2); 
outgrowth of fibroblasts generally took 2 weeks.  Once confluence was reached, the cells were 
transferred to 90 mm tissue culture dishes and cultured in standard media with 10% FBS.  
Thereafter, the confluent dishes were sub-cultured by trypsinization (1:3 split ratio).  Studies 
were conducted using passages 3-5 to maintain comparability to ensure normal phenotype of 
cells was not compromised.  Based on previous experience with these cells, variability is 
observed following splitting of cells more than 5 times.   
Lipofectamine-siRNA Transfection 
Macrophages (2.5 X 105) were seeded in a 6-well dish (Becton Dickinson, Franklin 
Lakes, NJ) transfected with 5 L of Lipofectamine RNAiMAX Reagent (Invitrogen, Carlsbad, 
CA; catalogue no. 13778-075) complexed with 150 picomoles of a specific siRNA (HIF-
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1TGF-1) in standard medium without antibiotics.  Macrophages were then placed in a 
standard tissue incubator (37°C; 95% air and 5% CO2) for 24-hrs.  
siRNA Design, Synthesis, and Labeling 
Small interfering RNAs were designed after determination of target sequences by 
aligning specific sequences (HIF-1TGF-1) to an Ambion Web-based algorithm.  The 
nucleotide duplex siRNA molecules with 2-dTdT overhangs, were resuspended in nuclease-free 
water according to the instructions of the manufacturer (Ambion).  To ensure a stringent control, 
a scrambled control sequence was obtained from Ambion (Silencer Negative Control No. 1 
siRNA; catalogue no. 4611). 
TGF-1 treatment 
TGF β 1 (2g) human recombinant was purchased from Sigma-Aldrich and dissolved in 
phosphate buffered saline containing 2 mg/mL bovine serum albumin to reach a concentration of 
20 g/mL.  Working concentrations (0, 375, 750, 1500 ng TGF-1/mL media) were prepared by 
further diluting the stock solution.   
Hypoxia Treatment 
Hypoxic experiments were performed in an airtight modular incubator chamber.  The 
chamber was deoxygenated by positive infusion of 2% O2 in a CO2-nitrogen gas mixture for 15 
minutes.  Cultures were then placed in a standard humidified tissue incubator.  There were no 
statistically significant differences in viability by crystal violet or trypan blue exclusion (data not 
shown).  Parallel cultures were placed in normoxic conditions for all experiments.  Cells were 
harvested after 24 hrs.  All experiments were performed in triplicate. 
Real-Time RT-PCR for HIF-1, VEGF, TGF-1, and type I collagen 
The real-time RT-PCR technique was used to detect and compare mRNA levels for each 
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experiment.  The advantage of the real-time RT-PCR method over the conventional PCR method 
is that it allows the determination of the absolute copy number of mRNA. 
RNA isolation  
Total RNA was extracted from normal peritoneal fibroblasts and macrophages using an 
RNeasy Mini Kit (Qiagen, Valencia, CA) according to the protocol provided by the 
manufacturer. 
Reverse transcription  
A 20uL cDNA reaction volume was prepared with the use of QuantiTect Reverse 
Transcription Kit (Qiagen), as described by the manufacturer’s protocol. 
Real-time RT-PCR analysis  
Optimal oligonucleotide primers for real-time RT-PCR amplification of reverse-
transcribed cDNA were selected with the aid of a commercial software program (Beacon 
Designer 7.0; Premier Biosoft, Palo Alto, CA).  Human oligonucleotide primers, which amplify 
variable portions of the protein coding regions, are summarized in Table 1 below.   
Table 1: Human Oligonucleotide Primers 
Locus Sense (5’-3’) Antisense (3’-5’) Product length 
TGF-1 AGTGGTTATCTTTTGATGTC GTAGTGAACCCGTTGATG 142 
VEGF GGAAACCAGCAGAAAGAGG AAGCAGGTCACTCACTTTG 132 
Type I Collagen CCTGTAAACTCCCTCCATCC AAGTCCATGTGAAATTGTCTCC 133 
HIF-1 AGCCGAGGAAGAACTATGAAC ACTGAGGTTGGTTACTGTTGG 100 
Real-time RT-PCR was performed with a QuantiTect SYBR Green RT-PCR Kit 
(Qiagen) and a Cepheid 1.2f Detection System (Cepheid, Sunnyvale, CA).  Reactions are 25-L 
volumes including 12.5 L of 2× QuantiTect SYBR Green RT-PCR Master Mix, 1 L of cDNA 
template, and 0.2 mol/L of each target-specific primer that were designed to amplify a portion 
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of each gene.  To quantify each target transcript, a standard curve was constructed with a 10-fold 
dilution series of a standard plasmid.  The three-step PCR protocol applied for HIF-1, VEGF, 
TGF-1, and type I collagen reactions consists of 45 cycles of 95°C for 15 seconds, 60°C (HIF-
1), 57°C (VEGF), 52°C (TGF-1), 58°C (type I collagen) for 30 seconds, and 72°C for 30 
seconds.  After PCR, a melting curve analysis will be performed to demonstrate the specificity of 
the PCR product as a single peak.  
Immuno-precipitation and Western Blot Analysis 
An antibody for HIF-1, VEGF, TGF-1, and type I collagen was incubated with 
nuclear/cytoplasmic protein extracted from normal peritoneal fibroblasts and macrophages.  The 
antibody/antigen complex was pulled out of the total protein sample using protein A/G-coupled 
agarose beads.  The sample was combined with Tris-Glycine SDS Sample Buffer (Invitrogen 
LC2676) and heated to 85ºC for 5 minutes to unfold the protein.  Proteins were separated on a 4-
20% Tris-Glycine gel (Invitrogen) at 130V for 180 minutes against a molecular weight ladder.  
Proteins were transferred from the gel to a nitrocellulose membrane using an electroblotting 
apparatus at 40V for 2 hrs.  
Non-specific protein binding was blocked by incubating the membrane for 30 min in 5% 
non-fat milk solution.  Membranes were washed 1X with wash buffer.  Primary antibody diluted 
in 1% non-fat milk solution for HIF-1, TGF-1, VEGF, type I collagen, and tubulin primary 
antibodies were incubated for 24 hrs at 4ºC.  Membranes were washed 4X in wash buffer and 
incubated for 1 hr at room temperature, with horse-radish peroxidase (HRP)-conjugated 
secondary antibody, in 2% non-fat milk.  Membranes were submerged in a chemiluminescence 
reagent (Millipore) for 5 min and developed.  Protein bands were scanned and analyzed by NIH 
image J 3.0. 
18 
 
Statistical Analysis 
Real-time RT-PCR and Western blot data was analyzed using paired t-tests.  Statistically 
significant differences for comparison of means were established at P<0.05.  All statistical 
analyses were performed using prism 4.0 for Windows. 
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CHAPTER 2 
Hypoxia Induces the Adhesion Phenotype Markers in Human Macrophages 
Introduction 
Emerging evidence suggests that macrophage dysfunction is an integral component of the 
pathogenesis of wound healing (78-81).  As a result, increased understanding of this 
multifunctional cell is an attractive therapeutic target to limit or prevent post-operative adhesion 
development.  The objective of this study is to determine whether human macrophages express 
adhesion phenotype markers TGF-1, type I collagen and VEGF, and whether this expression is 
induced by hypoxia exposure.   
It is well known that macrophages accumulate in poorly perfused, hypoxic sites, where 
comparable damage has occurred.  Inflammation is a prerequisite for healing and there is 
compelling evidence linking TGF-β production to wound macrophages and adhesion formation 
(82).  As mentioned previously, TGF-1 plays a role in chemotactically recruiting multiple cell 
types to the site of injury, including macrophages and fibroblasts, regulating angiogenesis, as 
well as extracellular matrix turnover (43-47).  Therefore, macrophages may mediate multiple 
wound healing processes through their production in TGF-1 alone.  Additionally, macrophages 
are well documented to produce abundant amounts of VEGF and therefore are considered to 
have pro-angiogenic capabilities following tissue trauma (82-84).  We hypothesize that hypoxia 
will induce significant changes in macrophage expression of the adhesion pehonotype markers.  
The rationale of this study is derived from extensive data from our laboratory and others 
indicating that hypoxia exposure irreversibly induces the development of the adhesion phenotype 
in fibroblasts (1, 28-34).  The significance of this aim is that macrophages represent a role not 
only for protecting tissues from invading pathogens and toxicants but also for initiating and 
promoting the development of post-operative adhesions.  Understanding the role of macrophages 
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in the pathogenesis of post-operative adhesions may lead to the development of better and more 
efficacious approaches for treating and/or preventing adhesion development.  
Design 
To accomplish this aim, we measured the levels of select adhesion phenotype markers in 
macrophages following hypoxia exposure.  Macrophages (1.0 X 107 cells) were cultured in 10 
mL of standard media [Dulbecco’s modified media supplemented with 10% fetal bovine serum 
(FBS) and 2% of streptomycin and penicillin] under normal (20%O2) and hypoxic (2% O2) 
conditions, for 24 hrs.  After 24 hr incubation macrophages and media were centrifuged at 1800 
RPM for 5 min.  Macrophages were collected from normal and hypoxic cultures, protein and 
RNA extracted, cDNA synthesized, and analysis performed. 
Real-time RT-PCR was utilized to measure mRNA levels for TGF-1, type I collagen, 
and VEGF.  This method is well established in our laboratory and all primer sets for each gene 
target have been validated.  Additionally, western blot analysis was utilized to correlate TGF-1 
and VEGF protein with mRNA levels.  Collectively, this experimental design should yield 
insight into the expression of the adhesion phenotype markers, by macrophages, under normal 
and hypoxic conditions. 
Results 
Macrophages manifest increased expression of the adhesion phenotype markers following 
exposure to hypoxia:   
Total RNA isolated from human macrophages cultured under normal and hypoxic 
conditions were subjected to real time RT/PCR to determine whether macrophages express 
baseline levels of select adhesion phenotype markers including TGF-1, type I collagen, and 
VEGF and whether hypoxia regulates this expression.  As shown in Figures 1-3, macrophages 
express TGF-1, VEGF, and type I collagen and hypoxia resulted in a significant increase in this 
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Figure 1: Comparison of TGF-β1 mRNA levels in 
human macrophages before and after hypoxia 
exposure. Results are representative of the mean of three 
independent experiments. 
 
 
Figure 2: Comparison of VEGF mRNA levels in 
human macrophages before and after hypoxia 
exposure. Results are representative of the mean of three 
independent experiments. 
 
 
 
Figure 3: Comparison of type I collagen mRNA levels 
in human macrophages before and after hypoxia 
exposure. Results are representative of the mean of three 
independent experiments. 
 
expression when compared to normoxic conditions [from 11.23 to 14.01 pg TGF-1/g mRNA, 
from 2.38 to 10.7 pg VEGF/g mRNA, and from 0.03 to 0.12 pg type I collagen/g mRNA, 
respectively; each p<0.05].   
Additionally, as shown in Figures 4-5, hypoxia resulted in a significant increase in TGF-
1 and VEGF protein levels [from 27.7 to 39.1 and from 69.0 to 192.9, respectively; p < 0.05], 
when compared to normoxic conditions. 
 
Figure 4: Comparison of TGF-1 protein levels 
in human macrophages before and after 
hypoxia exposure. Results are representative of 
the mean of three independent experiments. 
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Figure 5: Comparison of VEGF protein levels in 
human macrophages before and after hypoxia 
exposure. Results are representative of the mean of 
three independent experiments. 
 
 
 
Conclusion 
The role of macrophages in post-operative adhesion development is not well defined.  
During the healing of the peritoneum, macrophage secretory activity is rarely the sole source for 
factors involved in peritoneal healing.  Many other cell types within the peritoneum, including 
other immune cells, fibroblasts, and mesothelial cells, are also involved in this process.  In this 
study we have shown that macrophages may contribute to the development of adhesions by 
expressing the adhesion phenotype markers TGF-1, type I collagen and VEGF.  Similar to 
normal peritoneal fibroblasts, hypoxia exposure induces a significant increase in TGF-1, type I 
collagen and VEGF in human macrophages (1, 28-34).  Future studies encompassing additional 
factors secreted in macrophages, following surgical trauma, would be a valuable tool to fully 
elucidating the role of macrophages in the pathogenesis of post-operative adhesions.    
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CHAPTER 3 
Silencing TGF-1 and HIF-1 Gene Expression Significantly Decreased the Adhesion 
Phenotype Markers in Macrophages 
Introduction 
In the previous study we have shown that macrophages express basal levels of select 
adhesion phenotype markers including TGF-1, type I collagen, and VEGF.  Additionally we 
have shown that hypoxia further induces the expression of these markers in macrophages.  The 
objective of this aim is to determine whether TGF-1, type I collagen, and VEGF expression is 
mediated by a HIF-1 and/or TGF-1 dependent mechanism following hypoxia exposure.  We 
hypothesize that surgical-induced hypoxia triggers a pro-inflammatory signal, leading to the 
activation and recruitment of resident and infiltrating macrophages to traumatized tissue, which 
may contribute to the development of the adhesion phenotype, a process we believe is mediated 
by HIF-1 and TGF-1.  The rationale of this study was derived from extensive data in our 
laboratory and others indicating that HIF-1 mediates multiple stages of peritoneal healing 
following hypoxia exposure, and that TGF-1 regulates multiple stages of peritoneal healing.  
The significance of this aim is to provide insight into mechanisms involving peritoneal healing 
in macrophages.  Understanding the nature of these mechanisms in macrophages will further 
highlight their role in peritoneal healing and also demonstrate specific mechanisms involved in 
the pathogenesis of postoperative adhesions which may lead to the development of better and 
more efficacious approaches for treating and/or preventing adhesions. 
Design 
To accomplish this aim real-time RT-PCR and small interfering RNA (siRNA) 
technology were utilized to assess HIF-1TGF-1, type I collagen, and VEGF gene expression 
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in response to hypoxia in human macrophages.  Macrophages (2.5 X 105) were seeded in a 6-
well dish (Becton Dickinson, Franklin Lakes, NJ) transfected with 5 μL of Lipofectamine 
RNAiMAX Reagent (Invitrogen, Carlsbad, CA; catalogue no. 13778-075) complexed with 150 
picomoles of a specific siRNA (HIF-1TGF-1) in standard medium without antibiotics.  
Macrophages were then placed in a standard tissue incubator (37°C; 95% air and 5% CO2) for 
24-hrs.  Following the initial incubation period macrophages were placed under normal (20% O2) 
and hypoxic (2% O2) conditions for an additional 24 hrs.  Macrophages were collected from 
normal and hypoxic cultures, protein and RNA extracted, cDNA synthesized, and analysis 
performed. 
Total RNA from each group was subjected to real-time RT/PCR to measure HIF-
1TGF-1, type I collagen, and VEGF mRNA levels.  Additionally, western blot analysis was 
utilized to correlate HIF-1TGF-1, and VEGF protein with mRNA levels.  Collectively, this 
experimental design should yield insight into mechanisms involved in the expression of the 
adhesion phenotype markers, by macrophages, under normal and hypoxic conditions. 
Results 
Silencing HIF-1 gene expression significantly decreased TGF-1, VEGF, and type I 
collagen expression in human macrophages under hypoxic conditions:  
Total RNA isolated from human macrophages cultured under normal and hypoxic 
conditions were subjected to real time RT/PCR to determine the effects of hypoxia on HIF-1, 
TGF-1, type I collagen, and VEGF expression.  As shown in Figures 6-9, hypoxia resulted in a 
significant increase in HIF-1, TGF-1, VEGF, and type I collagen expression when compared 
to normoxic conditions [from 0.32 to 0.42 pg HIF-1/g mRNA, from 11.23 to 14.01 pg TGF- 
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1/g mRNA, from 2.38 to 10.7 pg VEGF/g mRNA, and from 0.03 to 0.12 pg type I 
collagen/g mRNA, respectively; each p<0.05].  In contrast, silencing HIF-1 under hypoxic 
conditions resulted in a significant decrease in HIF-1, TGF-1, type I collagen, and VEGF 
when compared to hypoxia alone without silencing HIF-1 as shown in Figures 6-9 [from 0.42 
to 0.21 pg HIF-1/g mRNA, from 14.01 to 5.77 pg TGF-1/g mRNA, from 10.74 to 3.07 pg 
VEGF/g mRNA, and from 0.12 to 0.08 pg type I collagen/g mRNA, respectively; each 
p<0.05].  
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Additionally, total protein isolated from human macrophages cultured under normal and 
hypoxic conditions were subjected to Western blot analysis to determine the effects of hypoxia 
on TGF-1 and VEGF protein levels.  Hypoxia resulted in a significant increase in TGF-1 and 
VEGF [from 27.7 to 39.1 and from 69.0 to 192.9, respectively; p < 0.05] when compared to 
normoxic conditions, as shown in Figures 10-11.  In contrast, silencing HIF-1 gene expression 
resulted in a significant decrease in TGF-1 and VEGF [from 39.07 to 23.10 and from 192.87 to 
93.90, respectively; p < 0.05] when compared to hypoxic conditions, as shown in Figures 10-11.   
 
Silencing TGF-1 gene expression significantly decreased type I collagen, and VEGF levels in 
human macrophages under hypoxic conditions: 
As shown in Figures 12-14, hypoxia resulted in a significant increase in TGF-1, VEGF, 
and type I collagen expression when compared to normoxic conditions [from 47.53 to 130.30 fg 
TGF-1/g mRNA, from 1258.30 to 1655.01 fg VEGF/g mRNA, and from 23.68 to 53.31 fg 
type I collagen/g mRNA, respectively; p<0.05].  In contrast, hypoxia with TGF-1 knockdown 
resulted in a reversal of the effects of hypoxia, with a significant decrease in TGF-1, VEGF, 
and type I collagen when compared to hypoxia alone [from 130.30 to 38.23 fg TGF-1/g 
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mRNA, from 1655.01 to 1157.72 fg VEGF/g 
mRNA, and from 53.31 to 15.12 fg type I 
collagen/g mRNA, respectively; p<0.05).  
Conclusion 
To compensate for low oxygen 
conditions (hypoxia) cells activate a number of 
adaptive responses to stabilize O2 levels to 
maintain metabolic, bioenergetic, and redox 
demands.  HIF-1 is a major transcriptional 
regulator of hypoxic stress (85-86).  When O2 
levels are adequate PHD modifies HIF-1 
which leads to polyubiquitination by VHL 
(35-37).  Thus, modified HIF-1 is a target for 
proteosomal destruction by an E3 ubiquitin 
ligase.  Under hypoxic stress, PHD activity is 
diminished, thereby stabilizing HIF-
1.   
Insight into mechanisms regulating 
HIF protein has lead to clinical applications in 
ischemic disease (35-38).  The most prominent 
involve PHD inhibitors though HIF-1 
activators/inhibitors are becoming increasingly 
popular (85).  In some cases, HIF-1 activation promotes disease progression, while in others, 
 
Figure 12: Comparison of TGF-1 mRNA 
levels in human macrophages following 
hypoxia exposure with and without TGF-1 
knock down. Results are representative of the 
mean of three independent experiments. 
 
Figure 13: Comparison of VEGF mRNA 
levels in human macrophages following 
hypoxia exposure with and without TGF-1 
knock down. Results are representative of the 
mean of three independent experiments. 
 
Figure 14: Comparison of type I collagen 
mRNA levels in human macrophages 
following hypoxia exposure with and 
without TGF-1 knock down. Results are 
representative of the mean of three independent 
experiments.
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HIF inhibitory responses are a part of disease recovery (85).  Overall, these findings support a 
role for HIF-dependent therapies in preventing adhesion development. 
In addition to HIF-1, the TGF- system regulates a plethora of biological processes that 
may be involved in peritoneal healing.  It has been shown that alterations in TGF- expression 
contribute to a broad range of pathologies, including fibrosis and adhesion development (87).  
The fibrotic reaction is characterized by an increased production of ECM components, such as 
type I collagen, as well as, proliferation, migration and accumulation of various cells (87).  Due 
to TGF- promiscuity the TGF- signaling pathway has been an attractive target for therapy in a 
number of diseases.  The therapeutic approach is dependent on the disease and may involve the 
inhibition/activation of the pathway.  Inhibitory treatments include ligand traps, such as ligand-
specific neutralizing antibodies, soluble ligand receptors, antisense-dependent silencing of 
ligands and chemical inhibitors that block kinase activity of TGF- receptors (87).  Conversely, 
increased ligand-dependent signaling may be beneficial for therapeutic purposes.  For example, 
recombinant human bone morphogenetic proteins (BMPs) activate the bone regenerative 
properties of the BMP pathway (87).  Additionally, several preclinical studies have assessed the 
efficacy of endogenous/synthetic Smad inhibitors, Smad sequestration, or targeting degradation 
in several diseases in vitro and in vivo (87).  A comprehensive understanding of TGF- signaling 
and regulation in additional cell types, including macrophages, will further provide targets for 
treatment of diseases caused by malfunctioning of the TGF-β signaling pathway.  
In the past, increased understanding of the cellular and molecular events promoting 
adhesion formation has led to the identification of many biologically active molecules with the 
potential of regulating events that are central to normal peritoneal and adhesion formation (4).  In 
this study we have shown that hypoxia exposure resulted in a significant increase in HIF-1, 
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TGF-1, type I collagen, and VEGF expression in human macrophages.  Silencing HIF-1gene 
expression under hypoxic conditions resulted in a significant decrease in TGF-1, type I 
collagen, and VEGF levels.  Additionally, silencing TGF-1 gene expression under hypoxic 
conditions resulted in a significant decrease in both type I collagen, and VEGF levels.  
Collectively, results from this study has shown that HIF-1and TGF down-regulation will 
indeed minimize the expression of TGF-1, type I collagen, and VEGF which provides 
additional insight into mechanisms capable of reducing adhesions in vivo.  This study validates 
HIF-1as well as TGF as a potential target in post-operative adhesion prevention and 
directs us towards evaluating similar mechanisms involved in in vivo animal models.  
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CHAPTER 4 
Macrophages Induce the Adhesion Phenotype in Normal Peritoneal Fibroblasts 
Introduction 
The inflammatory response activates the innate immune system which stimulates the 
recruitment of macrophages from circulation (82-84).  Macrophages influence peritoneal healing 
by regulating specific factors involved in repair mechanisms.  Hypoxia is known to induce 
marked changes in these processes by increasing the secretory activity of macrophages, which 
elicits angiogenesis, ECM turnover, inflammation, and phagocytosis (78-79, 82-84).   
In addition to macrophages, the role of fibroblasts has also been illustrated in wound 
healing.  More specifically, fibroblasts secrete ECM proteins resulting in wound contraction and 
scar formation (88-89).  We have shown that hypoxia alters the phenotype of fibroblasts by 
altering an array of wound healing processes including a reduction in plasminogen activator 
activity (lower tPA and higher PAI-I), increased angiogenesis (VEGF), increased extracellular 
matrix deposition (higher type I collagen and fibronectin), increased cytokine production (higher 
TGF-1), and reduced apoptosis (higher Bcl and lower Bax), collectively referred to as the 
“adhesion phenotype” (1, 11-16).  
Coupled with hypoxia, TGF-1 is believed to coordinate macrophage and fibroblast role 
in wound healing by its ability to chemotactically recruit fibroblasts and macrophages to the site 
of injury, regulate angiogenesis, as well as, tissue remodeling tissue remodeling (43-47).  We 
have shown that hypoxia increases the expression of TGF1 in multiple cell types which 
further supports the role for this cytokine in wound healing (28, 30, 48-50). 
The objective of this study is to determine whether macrophages, exposed to hypoxia, 
stimulates primary cultures of fibroblasts to acquire the adhesion phenotype.  We hypothesized 
that surgical-induced hypoxia triggers macrophages to release factors, more specifically TGF-1, 
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with the capability of inducing the adhesion phenotype in normal peritoneal fibroblasts by 
modulating factors involved in wound healing.  The rationale of this study was derived from 
extensive data in our laboratory and others indicating that macrophages express TGF-1 and that 
hypoxia induces this expression.  The significance of this aim will elucidate the cooperative 
aspects of cell-to-cell interactions, comprised of macrophage and fibroblasts, that are 
representative of in vivo microenvironments. 
Design 
To accomplish this aim media collected from human macrophages cultured under 
hypoxic conditions (2% O2) were used to treat normal peritoneal fibroblasts.  Macrophages (1.0 
X 107 cells) were cultured in 10 mL of standard media [Dulbecco’s modified media 
supplemented with 10% fetal bovine serum (FBS) and 2% of streptomycin and penicillin] under 
normal (20%O2) and hypoxic (2% O2) conditions, for 24 hrs.  After 24 hr incubation 
macrophages and media were centrifuged at 1800 RPM for 5 min.  Media (10 mL) collected 
from normal and hypoxic macrophage cultures were used to culture normal peritoneal fibroblasts 
(1.0 x 107 cells) under normal oxygen (20% O2) conditions in a standard tissue incubator for 24 
hrs.  Additionally, human peritoneal fibroblasts (5 X 106) were cultured in a 6-well dish with 0, 
12.5, 25, and 50 ng TGF-1 and then placed in a humidified tissue incubator for 24 hours. 
Total RNA from each group was subjected to real-time RT/PCR to measure HIF-TGF-
1, type I collagen, and VEGF mRNA levels.  Additionally, western blot analysis was utilized to 
correlate TGF-1, type I collagen, and VEGF protein with mRNA levels. Collectively, this 
experimental design should yield insight into the role of fibroblasts and macrophages in 
peritoneal wound healing, thus emphasizing the synergistic interaction of different cell types 
involved in adhesion development.   
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Results 
Hypoxia treatment resulted in a significant increase in TGF-1 expression in human 
macrophages:   
As shown in Figures 1 & 4, hypoxia resulted in a significant increase in TGF-1 mRNA 
and protein levels [26.8%, respectively; p < 0.05)], when compared to normoxic conditions. 
Hypoxia treatment resulted in a significant increase in TGF-1, VEGF, and type I collagen 
mRNA levels in normal peritoneal fibroblasts:   
As shown in Figure 15, hypoxia resulted in a significant increase in TGF-1 [26.8%; p < 
0.05)], VEGF [86.4%; p < 0.05)], and type I Collagen [35.1%; p < 0.05)] when compared to 
normoxic conditions. 
Figure 15: Hypoxia treatment resulted in a significant 
increase in TGF-β1, VEGF, and type I collagen 
mRNA levels in human peritoneal fibroblasts: 
Comparison of TGF-β1, VEGF, and type I collagen 
mRNA levels in normal peritoneal fibroblasts before and 
after hypoxia (2% O2) exposure. Results are 
representative of the mean of three independent patients. 
 
 
Hypoxia treatment resulted in a significant increase in TGF-1, VEGF, and type I collagen   
protein levels in normal peritoneal fibroblasts:   
As shown in Figure 16, hypoxia resulted in an increase in TGF-1 (28.6%), VEGF 
(39.0%), and type I collagen (9.8%) protein levels. 
Figure 16: Hypoxia treatment resulted in an increase 
in TGF-β1, VEGF, and type I collagen protein levels 
in human peritoneal fibroblasts: Comparison of TGF-
β1, VEGF, and type I collagen protein levels in normal 
peritoneal fibroblasts before and after hypoxia (2% O2) 
exposure. Results are representative of the mean of 
three independent patients. 
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Macrophage secretion significantly increased TGF-1, VEGF, type I collagen mRNA levels in 
normal peritoneal fibroblasts under hypoxic conditions:   
As shown in Figure 17 normal peritoneal fibroblasts cultured with media collected from 
macrophages following hypoxia exposure resulted in a significant increase in TGF-1 [11.2%; 
p< 0.05)], VEGF [51.2%; p < 0.05)], and type I Collagen [28.8%; p < 0.05)] mRNA levels when 
compared to normal peritoneal fibroblasts cultured with media collected from macrophages 
cultured under normal conditions. 
 
Hypoxia treatment resulted in a significant increase in TGF-1, VEGF, and type I collagen 
protein levels in normal peritoneal fibroblasts:   
As shown in Figure 18, hypoxic-macrophage media resulted in an increase in TGF-1 
(47.0 %), VEGF (3.1%), and type I collagen (78.2%) protein levels. 
 
Figure 18: Macrophage secretion, following 
hypoxia exposure, significantly increased 
TGF-β1, VEGF, type I collagen protein 
levels in human peritoneal fibroblasts: 
Comparison of TGF-β1, VEGF, & type I 
collagen protein levels in normal peritoneal 
fibroblasts following incubation with media 
collected from macrophages cultured under 
normal and hypoxic conditions.  
Figure 17: Macrophage secretion, following 
hypoxia exposure, significantly increased 
TGF-β1, VEGF, type I collagen mRNA 
levels in human peritoneal  fibroblasts: 
Comparison of TGF- β1, VEGF, and type I 
collagen mRNA levels in normal peritoneal 
fibroblasts following incubation with media 
collected from macrophages cultured under 
normal and hypoxic conditions. Results are 
representative of the mean of three 
independent patients. 
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TGF-β1 regulation is dose-dependent:   
Normal peritoneal fibroblasts exposed to 
varying concentrations of TGF-1 exhibited a dose-
dependent response in TGF-1, VEGF, and type-I 
collagen mRNA levels (Figure 19A-C).  At a low 
TGF-1 concentration (12.5 ng TGF-1/mL media), 
TGF-1 [(19A) increased from 0.9 to 1.4 pg 
TGFg mRNA; p < 0.05)], VEGF [(19B) 
increased from 0.6 to 1.6 pg VEGFg mRNA; 
p<0.05)], and type I Collagen [(19C) increased from 
0.3 to 0.6 pg type I Collagen/g mRNA; p < 0.05)] 
were significantly increased when compared to 
baseline TGF-1 levels.  In contrast, at higher TGF-
1 concentrations (25 and 50 ng TGF-1/mL 
media), TGF-1 [(19C) declined from 1.4 to 1.3 to 
1.1 pg TGFg mRNA; p < 0.05)], VEGF 
[(19C) declined from 1.6 to 0.9 to 0.2 pg VEGF/g 
mRNA; p < 0.05)], and type I Collagen [(19-C) 
declined from 0.6 to 0.5 to 0.3 pg type I Collagen/g 
mRNA; p < 0.05)]  mRNA levels were significantly 
reduced when compared to peak (12.5 ng TGF-
1/mL media) TGF-1 levels. 
Figure 19: TGF-β1 regulation is 
dose-dependent: Comparison of TGF-
β1 (19A), VEGF (19B), & type I 
collagen (19C) mRNA levels in human 
peritoneal fibroblasts in response to 
varying TGF-β1 concentrations (0, 
12.5, 25, & 50 ng TGF-β1/mL media). 
Representative of the mean of three 
independent experiments. 
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Conclusion 
In the present study normal peritoneal fibroblasts were cultured under normal and 
hypoxic conditions.  In addition, media collected from macrophage cultures, with and without 
hypoxia exposure, was utilized to culture normal human peritoneal fibroblasts.  Base-line levels 
for adhesion markers varied from patient to patient.  Our results indicate similar trends for each 
experimental condition.  Consistent with previous findings we have shown that TGF-β1, VEGF, 
and type I collagen is significantly increased in normal peritoneal fibroblasts following hypoxia 
exposure (1).  Additionally, this study indicates that macrophage conditioned media encompass 
specific factors promoting TGF-β1, VEGF, and type I collagen expression in normal peritoneal 
fibroblasts, thus implicating macrophages as a major contributor to the development of the 
adhesion phenotype.  In this study we suggest that hypoxia-induced TGF-β1 expression mediates 
the induction of the adhesion phenotype in normal peritoneal fibroblasts. 
This hypothesis has been formulated on the basis of strong preliminary and published 
data, which supports the role of TGF-β1 in inflammation, angiogenesis, and extracellular matrix 
(ECM) turnover under normal conditions (43-47).  Excessive TGF- exposure exaggerates these 
processes thus promoting the development of adhesions (43).  We have shown that TGF-β1 
regulates VEGF and type I collagen as well as its own expression TGF-β1 regulation occurs by a 
dose-dependent mechanism (19, 45, 90, 91, 92).  For example, we have shown that a low 
concentration (12.5 ng TGF-β1/mL media) of TGF-β1 resulted in increased expression of VEGF 
and type I collagen, as well as, TGF β 1 itself.  However, higher concentrations of TGF-β1 (25 
ng and 50 ng TGF-β1/mL media) resulted in decreased expression of VEGF and type I collagen, 
as well as TGF-β1.  These findings indicate that TGF-β1 secreted by macrophages, in response 
to hypoxia exposure, is partly responsible for the induction of the adhesion phenotype markers, 
VEGF and type I collagen, as well as its own expression in normal peritoneal fibroblasts.  
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Therefore, this study not only confirms the biphasic response of TGF-β1 in normal peritoneal 
fibroblasts but also emphasize its major role in the development of the adhesion phenotype 
involving both autocrine and paracrine mechanisms (91).    
Collectively, results from this study support the role of fibroblasts and macrophages in 
peritoneal wound healing, thus emphasizing the synergistic effect of multiple cells involved in 
adhesion development.   
37 
 
CHAPTER 5 
Discussion 
To date, minimal insight involving the role of macrophages in post-operative adhesion 
development exists.  This study is novel because it highlights a role for the innate immune 
system in the pathogenesis of peritoneal wound healing and adhesion development.  We have 
shown that macrophages express basal levels of adhesion phenotype markers:  TGF-1, VEGF, 
and type I collagen.  Hypoxia enhances the expression of TGF-1, VEGF, and type I collagen 
through a HIF-1 and TGF-1 dependent mechanism.  Additionally, macrophages exposed to 
hypoxia release specific factors that are responsible for inducing the adhesion phenotype in 
normal peritoneal fibroblasts.  More specifically, hypoxia-induced TGF-1 expression, in 
macrophages, mediates this response through a dose-dependent mechanism.   
The innate immune system is activated immediately following injury.  Subsequent release 
of inflammatory mediators drives recruitment of inflammatory cells from circulation.  This rapid 
response triggers activation and recruitment of resident and infiltrating macrophages to the site 
of injury.  Hypoxia exaggerates the inflammatory response.  Specifically, hypoxia stimulates 
numerous cell types, including macrophages, to produce inflammatory mediators, such as TGF-
, that are paramount to inflammation (82).  HIF-1, a major regulator of oxygen deficiency, 
mediates TGF-1 expression under hypoxic conditions. Lack of TGF- signaling substantially 
diminishes the inflammatory response (83).  Hence, TGF-β-deficient SMAD3 knockouts recruit 
macrophages poorly into skin wounds (83).  Likewise, we have shown that human macrophages 
express TGF-1 and hypoxia enhances this expression through a HIF-1 mediated mechanism.  
Therefore, results from this study support the role of macrophages in wound healing partially by 
their ability to express TGF-1, a major inflammatory cytokine.   
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Hypoxia, a result of surgical trauma, also triggers angiogenesis to re-establish oxygen 
availability.  Neovascularization during granulation tissue formation in wounds is controlled by a 
variety of cytokines and growth factors, including TGF-1 and VEGF.  VEGF plays a central 
role in neovascularization.  TGF-1 induces VEGF expression (45).  Smad3 and HIF-1 
cooperate with TGF- to induce VEGF transcription in humans (45).  As mentioned previously, 
excessive vascularization promotes adhesion viability and therefore therapeutic applications 
targeting angiogenic pathways, specifically VEGF, have been explored.  There is compelling 
evidence linking macrophages to angiogenesis (45, 82-83).  More specifically, in a study 
utilizing macrophage-deficient mice abnormal vascularization was observed in macrophage-
depleted wound models (82).  Also, treatment of macrophages with anti-VEGF antibody 
neutralized the angiogenic activity of human wound fluids in vitro (82).  In support of these 
findings, our current study reveals that macrophages express basal levels of VEGF and that 
hypoxia induces VEGF expression through a HIF-1 and TGF-1-dependent mechanism.  
Additionally we have shown that hypoxia-induced TGF-1 expression in macrophages enhances 
angiogenic pathways in normal peritoneal fibroblasts.  
In addition to macrophages role in angiogenesis we have also shown that macrophages 
play an important role in extracellular matrix turnover, a critical process in wound healing.  Type 
I collagen is the most abundant ECM protein.  Collagen synthesis is critically dependent on the 
availability of molecular oxygen in tissue culture, animal, and human wound healing 
experiments.  Thus, hypoxia promotes collagen deposition.  As mentioned previously, the 
balance between the expression of MMPs and TIMPs is critical to normal wound healing.  
Hypoxia inhibits the expression of MMPs and increases TIMPs, thus decreasing matrix 
degradation and increasing fibrosis.  Therefore, increased expression of type I collagen combined 
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with decreased proteolytic activity within the peritoneal cavity, under hypoxic conditions, 
perpetuates adhesion development.  In addition to hypoxia TGF-1 is known to increase type I 
collagen expression and decrease MMP expression which furthers promotes adhesion 
development.  Similarly, our current study, utilizing macrophage cultures, supports these 
findings.  We have shown that macrophages express basal levels of type I collagen and that 
hypoxia induces type I collagen expression through a HIF-1 and TGF-1-dependent 
mechanism.  Additionally we have shown that hypoxia-induced TGF-1 expression in 
macrophages enhances collagen deposition by normal peritoneal fibroblasts. 
Indeed results from our study highlight an important role of macrophages in the 
pathogenesis of peritoneal wound healing.  We have shown that peritoneal macrophages regulate 
key processes involved in the pathophysiology of post-operative adhesion development including 
inflammation, angiogenesis, and ECM turnover through their production of TGF-1, VEGF, and 
type I collagen, respectively.  Additionally, we have shown that macrophages exposed to 
hypoxia elicit conditions favorable for adhesion development by enhancing the expression of 
specific adhesion phenotype markers:  TGF-1, VEGF, and type I collagen.  HIF-1 and TGF-
1 mediate hypoxia effects in macrophages.  Additionally, we have proven a synergy that exists 
between macrophages and normal peritoneal fibroblasts that promotes the development of the 
adhesion phenotype.   
Further understanding the nature of additional factors and the relative contributions of 
macrophages activated by other mechanisms, such as infection and predisposing diseases, may 
lead to the development of better and more efficacious approaches for treating and/or preventing 
adhesion development.  Surgical trauma, infection, and predisposing diseases, such as 
endometriosis, exaggerate the inflammatory response and subsequently lead to macrophage 
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recruitment.  As we have shown, macrophage responses to hypoxia are central to these events.  
Relatively few studies have shown the effects of hypoxia on macrophages in the presence of co-
stimuli, such as LPS and IFN- which may provide further insight in macrophage activity under 
these conditions.  Future studies in our laboratory would examine the role of these stimuli and 
others that are present following tissue trauma and disease including glucose depletion, 
accumulation of lactic acid and other metabolic byproducts, and low pH.  Examination of 
macrophage activity under these conditions may provide a better picture.  Once mechanisms are 
better understood it would be possible to block their activity or manipulate their involvement in 
peritoneal wound healing.  Additional co-culture models could be explored to better understand 
the synergistic/antagonistic effects that exist amongst different cell populations, which is more 
representative of what occurs in vivo.  Also, translating these in vitro studies into an animal 
model would be advantageous and confirm our current findings. 
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ABSTRACT 
THE POTENIAL ROLE OF INNATE IMMUNITY IN THE PATHOGENESIS OF POST-
OPERATIVE ADHESIONS 
by 
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Degree: Doctor of Philosophy 
Post-operative adhesion development occurs in the vast majority of patients following 
abdominal surgery and is a natural occurrence of peritoneal-wound healing.  These fibrous bands 
may form within the first 5-7 days post-surgery and have the ability to cause a distortion in the 
normal anatomical positioning of abdominal organs.  Consequently, adhesions are major 
contributors to small bowel obstruction, infertility, and severe pelvic and abdominal pain.  
Physiological processes responsible for adhesion formation remain obscure though it is believed 
to involve cell migration, proliferation, and differentiation of several cell types including 
mesothelial cells, fibroblasts, and inflammatory and immune cells.  Substances released from 
these cells regulate fibrinolytic activity, tissue remodeling, angiogenesis, and extracellular matrix 
turnover, processes that are known to be central to the development of adhesions.  Our long-term 
goal is to prevent or selectively limit the development of post-operative adhesions. The objective 
of this study is to determine the role that macrophages play in the development of post-operative 
adhesions.  Our central hypothesis states that surgical-induced hypoxia triggers a pro-
inflammatory signal, leading to the activation and recruitment of resident and infiltrating 
macrophages, which contribute to the development of the adhesion phenotype. This hypothesis 
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has been formulated on the basis of strong preliminary and published data, which suggest that 
hypoxia plays a major role in the development of the adhesion phenotype.  Indeed, we have 
shown that exposure of normal peritoneal fibroblasts to hypoxia, irreversibly, induces the 
adhesion phenotype.  This phenotype is characterized by a reduction in plasminogen activator 
activity, increased extracellular matrix deposition, increased cytokine production, and reduced 
apoptosis.  In this study we have shown that macrophages express basal levels of adhesion 
phenotype markers:  TGF-1, VEGF, and type I collagen.  Hypoxia enhances the expression of 
TGF-1, VEGF, and type I collagen through a HIF-1 and TGF-1 dependent mechanism.  
Additionally, macrophages exposed to hypoxia release specific factors that are responsible for 
inducing the adhesion phenotype in normal peritoneal fibroblasts.  More specifically, hypoxia-
induced TGF-1 expression in macrophages mediates this response through a dose-dependent 
mechanism.  Collectively, results from this study highlight a role for the innate immune system 
in the pathogenesis of peritoneal wound healing and adhesion development. 
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